{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:30:09Z","timestamp":1786120209000,"version":"build-2736575974"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1097\/01.med.0000433059.78485.fa","type":"journal-article","created":{"date-parts":[[2013,8,23]],"date-time":"2013-08-23T05:37:10Z","timestamp":1377236230000},"page":"407-411","source":"Crossref","is-referenced-by-count":12,"title":["New medications for obesity management"],"prefix":"10.1097","volume":"20","author":[{"given":"Nadia","family":"Boulghassoul-Pietrzykowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Franceschelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Still","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-8-20211004","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2337\/diacare.27.1.155","article-title":"XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients.","volume":"27","author":"Torgerson","year":"2004","journal-title":"Diabetes Care"},{"key":"R3-8-20211004","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/sj.ijo.0802475","article-title":"Long-term pharmacotherapy for overweight and obesity: a systemic review and meta-analysis of randomized controlled trials.","volume":"27","author":"Padwal","year":"2003","journal-title":"Int J Obes Relat Metab Disord"},{"key":"R7-8-20211004","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/oby.2011.330","article-title":"Controlled-release phenterminetopiramate in severely obese adults: a randomized controlled trial (EQUIP).","volume":"20","author":"Allison","year":"2012","journal-title":"Obesity (Silver Spring)"},{"key":"R8-8-20211004","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(11)60205-5","article-title":"Effects of low-dose, controlled-release phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomized, placebo-controlled, phase 3 trail.","volume":"377","author":"Gadde","year":"2011","journal-title":"Lancet"},{"key":"R9-8-20211004","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3945\/ajcn.111.024927","article-title":"Two year sustained weight loss and metabolic benefits with controlled-release phenterminetopiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study.","volume":"95","author":"Garvey","year":"2012","journal-title":"Am J Clin Nutr"},{"key":"R11-8-20211004","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1124\/jpet.107.133348","article-title":"Lorcaserin, a novel selective human 5-hydroxytryptamine 2C agonist: in vitro and in vivo pharmacological characterization.","volume":"325","author":"Thomsen","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"R15-8-20211004","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2515\/therapie:2005065","article-title":"Serotonin 5-HT2C receptors as a target for the treatment of depressive and anxious states: focus on novel therapeutic strategies.","volume":"60","author":"Millan","year":"2005","journal-title":"Therapie"},{"key":"R16-8-20211004","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1056\/NEJMoa0909809","article-title":"Multicenter, placebo-controlled trial of lorcaserin for weight management.","volume":"363","author":"Smith","year":"2010","journal-title":"N Engl J Med"},{"key":"R17-8-20211004","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1038\/oby.2012.66","article-title":"Randomized placebo-controlled clinical trial of lorcaserin for weight loss in type 2 diabetes mellitus: the BLOOM-DM study.","volume":"20","author":"ONeil","year":"2012","journal-title":"Obesity"},{"key":"R19-8-20211004","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1517\/14656560902775750","article-title":"Bupropion and naltrexone: a review of their use individually and in combination for the treatment of obesity.","volume":"10","author":"Plodkowski","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"R20-8-20211004","first-page":"A179","article-title":"Bupropion and naltrexone interact synergistically to decrease food intake in mice.","volume":"15","author":"Sinnayah","year":"2007","journal-title":"Obesity"},{"key":"R21-8-20211004","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0140-6736(10)60888-4","article-title":"Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicenter, randomized, double-blind, placebo-controlled, phase 3 trial.","volume":"376","author":"Greenway","year":"2010","journal-title":"Lancet"},{"key":"R22-8-20211004","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/oby.2010.147","article-title":"Weight loss with naltrexone SRbupropion SR combination therapy as an adjunct to behavior modification: the COR-BMOD trial.","volume":"19","author":"Wadden","year":"2011","journal-title":"Obesity (Silver Spring)"}],"container-title":["Current Opinion in Endocrinology, Diabetes & Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01266029-201310000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:26:11Z","timestamp":1786047971000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01266029-201310000-00008"}},"subtitle":["changing the landscape of obesity treatment"],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/01.med.0000433059.78485.fa","relation":{},"ISSN":["1752-296X"],"issn-type":[{"value":"1752-296X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}